Cargando…
Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond (18)F-fluorodeoxyglucose positron emission tomography imaging: promising tracers on the horizon
Cardiovascular disease is the major cause of morbidity and mortality in developed countries and atherosclerosis is the major cause of cardiovascular disease. Atherosclerotic lesions obstruct blood flow in the arterial vessel wall and can rupture leading to the formation of occlusive thrombi. Convent...
Autores principales: | Bucerius, Jan, Dijkgraaf, Ingrid, Mottaghy, Felix M., Schurgers, Leon J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267660/ https://www.ncbi.nlm.nih.gov/pubmed/30302506 http://dx.doi.org/10.1007/s00259-018-4176-z |
Ejemplares similares
-
Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011) -
Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose
por: Zhu, Jing, et al.
Publicado: (2022) -
Positron emission tomography of the vulnerable atherosclerotic plaque in man – a contemporary review
por: Pedersen, Sune F, et al.
Publicado: (2014) -
Sodium [(18)F]Fluoride PET Can Efficiently Monitor In Vivo Atherosclerotic Plaque Calcification Progression and Treatment
por: Florea, Alexandru, et al.
Publicado: (2021) -
Thoracic positron emission tomography: (18)F-fluorodeoxyglucose and beyond
por: Jaykel, Timothy J., et al.
Publicado: (2020)